收肌管阻滞持续输注与间断推注对吗啡消耗的影响:随机盲法对照试验
本研究为随机盲法对照试验,纳入110例脊麻下全膝关节置换术患者,比较0.2%罗哌卡因经收肌管导管持续输注(7 mL/h)与间断推注(21 mL/3 h)的效果。主要结局术后0-2天阿片类药物消耗量两组无差异,疼痛与活动能力亦无差异,仅推注组术后第2天股四头肌肌力保留更优但未转化为活动改善。
要点
- 收肌管阻滞间断推注与持续输注的术后阿片消耗量无显著差异。
- 两种给药方式在静息和屈膝疼痛评分上无差异。
- 推注组术后第2天股四头肌肌力保留更优,但活动能力无改善。
核心结论
- 将收肌管阻滞给药方式从持续输注改为重复间断推注未减少阿片消耗、疼痛或改善活动能力。
研究设计与样本
- 随机、盲法、对照临床研究,纳入110例拟行脊麻下全膝关节置换术患者,最终分析107例。
- 患者经收肌管导管接受0.2%罗哌卡因,分为间断推注组(21 mL/3 h)或持续输注组(7 mL/h)。
- 主要结局为术后0-2天经患者自控镇痛的阿片类药物总消耗量(mg)。
主要发现
- 屈膝时疼痛平均差值2.6 mm(95%CI -2.9至8.0),静息时平均差值1.7 mm(95%CI -1.5至4.9),均无差异。
临床怎么用
- 收肌管阻滞选择持续输注或间断推注均可,不影响主要镇痛结局。
- 若关注股四头肌肌力保留,可考虑间断推注,但需注意活动能力未获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Based on the assumption that relatively large volumes of local anesthetic optimize an adductor canal block (ACB), we theorized that an ACB administered as repeated boluses would improve analgesia without compromising mobility, compared with a continuous infusion. METHODS: We performed a randomized, blinded, controlled study, including patients scheduled for total knee arthroplasty with spinal anesthesia. Patients received 0.2% ropivacaine via a catheter in the adductor canal administered as either repeated intermittent boluses (21 mL/3 h) or continuous infusion (7 mL/h). The primary outcome was total (postoperative day [POD], 0-2) opioid consumption (mg), administered as patient-controlled analgesia. Pain, ambulation, and quadriceps muscle strength were secondary outcomes. RESULTS: We randomized 110 patients, of whom 107 were analyzed. Total opioid consumption (POD, 0-2) was a median (range) of 23 mg (0-139) in the bolus group and 26 mg (3-120) in the infusion group (estimated median difference, 4 mg; 95% confidence interval [CI], -13 to 5; P = .29). Linear mixed-model analyses revealed no difference in pain during knee flexion (mean difference, 2.6 mm; 95% CI, -2.9 to 8.0) or at rest (mean difference, 1.7 mm; 95% CI, -1.5 to 4.9). Patients in the bolus group had improved quadriceps sparing on POD 2 (median difference, 7.4%; 95% CI, 0.5%-15.5%). However, this difference was not present on POD 1 or reflected in the ambulation tests (P > .05). CONCLUSIONS: Changing the mode of administration for an ACB from continuous infusion to repeated intermittent boluses did not decrease opioid consumption, pain, nor mobility.
引用
- Jaeger P, Baggesgaard J, Sørensen JK, et al. Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption: A Randomized, Blinded, Controlled Clinical Trial. Anesth Analg. 2018. PMID: 29293181. doi:10.1213/ANE.0000000000002747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。